Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care

Launched by HOLY FAMILY HOSPITAL, NAZARETH, ISRAEL · May 7, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how effective ultrasound (a type of imaging test) is in detecting blood loss after a cesarean delivery, compared to the standard lab tests that normally check for anemia (low blood levels) in new mothers. Postpartum hemorrhage, or excessive bleeding after childbirth, can lead to serious health issues, so it's important to find the best way to identify it quickly. The trial aims to see if ultrasound can provide results faster than traditional blood tests, helping doctors to better manage the health of new mothers during the critical bonding period with their babies.

To be eligible for this study, women must be over 18 years old and have delivered their baby by cesarean section. They should also be able to speak Hebrew or Arabic and agree to participate by signing a consent form. Those who cannot provide consent, have certain blood disorders, or need special medical care will not be included. While the study is not yet recruiting participants, those who join can expect to undergo ultrasound exams to monitor their recovery, helping ensure their well-being during this important time.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women who delivered by a cesarean section.
• • Age over 18.
• • Fluent in Hebrew or Arabic.
• • Signed informed consent form.
• Exclusion Criteria:
• • Lack of consent or inability to provide informed consent.
• • Inability to perform a post-surgical ultrasound, such as post-surgery hospitalization in the intensive care unit.
• • Women with preoperative coagulation disorders.
• • Women whose clinical condition requires a post-cesarean ultrasound examination.